How do you prevent bowel cancer through five simple lifestyles?

Share This Post

Among patients with bowel cancer, nearly half of the cases can be prevented by lifestyle changes.

Of the 42,000 people diagnosed each year, 95% are over 50 years old. Risk factors include overweight, smoking, alcoholism, and type 2 diabetes. Here are our recommendations that can help you reduce the probability of bowel cancer.

Not to reduce carbohydrate intake

Carbohydrates help speed up the flow of food in your body. It is best to stick to whole-wheat varieties:brown bread, rice and pasta or whole-wheat semolina or quinoa.These foods are also anti-inflammatory effects, it can help your gut,but also vitamin E important sources.

Eat more fruits and vegetables

Fruits and vegetables are essential for a healthy diet, especially because they are another major source of fiber. Studies have shown that ingesting large amounts of vitamin C can help reduce the risk of bowel cancer. Therefore,storage of oranges and other citrus fruits, plus peppers, berries and kiwi are necessary.

Limit in take of processed meat 

Charity Beating Bowel Cancer, said the disease with diet contains large amounts of red meat and processed meats have close ties.The agency recommends eating less than 500 grams of red meat per week. Processed meats such as bacon, ham and salami, and you will face a greater risk of colorectal cancer the risk.

Fish

Another option for meat is fish, especially oily varieties like salmon, mackerel, anchovy and sardines. 2016 King’s College London study shows that eating a few mouthfuls of oil per dayoffish can significantly reduce the risk of colorectal cancer. Because these types of fish are rich in omega 3 fatty acids and have anti-inflammatory properties. In addition, they also contain a lot of vitamin D, which also helps to control cancer.

Reduce alcohol intake

Reducing alcohol in take is a clear and simple prevention of colorectal cancer in the method. Don’t panic-you don’t need to give up completely. It may be less a drink or choose to drink point of alcohol lower content of beverages.

Website |  + posts

Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy.

Hau's expertise lies in cancer cell biology, where she has made significant contributions to understanding the complex interactions between immune cells and tumors.

Her research aims to enhance the efficacy of immunotherapies by manipulating the tumor microenvironment and exploring novel ways to activate and direct immune responses against cancer cells.

Throughout her career, Hau has collaborated with leading professors and researchers in the field of cancer treatment, both in the United States and China.

These international experiences have broadened her perspective and contributed to her innovative approach to cancer therapy development.

Hau's work is particularly focused on addressing the challenges of treating advanced and metastatic cancers. She has been involved in clinical trials evaluating the safety and efficacy of various immunotherapy approaches, including the promising Gamma Delta T cell therapy.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
CAR T-Cell therapy

Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment

CAR T cell therapy has transformed cancer treatment, especially in hematological malignancies. Treatment of solid tumors remains challenging due to their immunosuppressive tumor microenvironment. Combination with chemotherapy, immune checkpoint inhibitors, oncolytic viruses, and improved genetic engineering holds promise. Multimodal approaches enhance immune cell infiltration and persistence, raising efficacy. Evolving personalized methods will be instrumental in overcoming solid tumor resistance and improving patient outcomes.

How to prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies
CAR T-Cell therapy

How to prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies?

CAR T-cell therapy revolutionized cancer therapy, offering incredible success in the management of B-cell malignancies, but it is associated with severe infection risks secondary to immunosuppression. Preventive measures are pre-infusion screening, vaccination, and antimicrobial prophylaxis. Post-infusion, close surveillance for infection and cytokine release syndrome management are key. Long-term care includes the treatment of hypogammaglobulinemia, revaccination, and patient education. The approach ensures improved outcomes and reduces infection-related complications in patients receiving CD19-targeted CAR T-cell therapy.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

CancerFax is the most trusted online platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies.

Send your medical reports and get a free analysis.

🌟 Join us in the fight against cancer! 🌟

Привет,

CancerFax — это самая надежная онлайн-платформа, призванная предоставить людям, столкнувшимся с раком на поздних стадиях, доступ к революционным клеточным методам лечения.

Отправьте свои медицинские заключения и получите бесплатный анализ.

🌟 Присоединяйтесь к нам в борьбе с раком! 🌟